Catalent
CTLT
#1579
Rank
NZ$17.67 B
Marketcap
$97.42
Share price
-0.08%
Change (1 day)
22.36%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : NZ$9.93 B

According to Catalent's latest financial reports the company's total liabilities are NZ$9.93 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Catalent - Total liabilities on balance sheet (from 2013 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-06-30NZ$10.05 B9.67%
2022-06-30NZ$9.16 B32.31%
2021-06-30NZ$6.92 B4.56%
2020-06-30NZ$6.62 B14.32%
2019-06-30NZ$5.79 B13.95%
2018-06-30NZ$5.08 B36.36%
2017-06-30NZ$3.73 B7.94%
2016-06-30NZ$3.45 B-5.12%
2015-06-30NZ$3.64 B-7.66%
2014-06-30NZ$3.94 B-9.09%
2013-06-30NZ$4.33 B-0.22%
2012-06-30NZ$4.34 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
NZ$0.57 B-94.17%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.87 B-91.23%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$12.28 B 23.59%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
NZ$0.51 B-94.77%๐Ÿ‡บ๐Ÿ‡ธ USA